LCM
SSKN

Legato Capital Management’s Strata Skin Sciences SSKN Stock Holding History

Legato Capital Management’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,280
Closed -$13.6K – 621
2023
Q3 		$13.6K Sell
2,280
-1,268
-36% -$9.74K ﹤0.01% 552
2023
Q2 		$33.7K Hold
3,548
– – ﹤0.01% 566
2023
Q1 		$37.6K Hold
3,548
– – 0.01% 494
2022
Q4 		$28K Buy
+3,548
New +$30.4K 0.01% 499

Other funds holding SSKN

2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $6.06B AUM 28.9% 1-Year Est. Return

Legato Capital Management's SSKN Position: Q4 2023 in Review

Legato Capital Management sold out of Strata Skin Sciences (SSKN) in Q4 2023, closing a stake of 2,280 shares — an estimated $13.6K sold.

Legato Capital Management first reported a position in SSKN in Q4 2022 and held it in 4 quarters. The position peaked at $37.6K in Q1 2023. 25 funds tracked by Wall St. Rank hold SSKN as of Q4 2023.

  • Legato Capital Management reported no remaining Strata Skin Sciences position as of Q4 2023 after selling out during the quarter.
  • Legato Capital Management sold 2,280 Strata Skin Sciences shares in Q4 2023, an estimated $13.6K.
  • Legato Capital Management first reported a position in Strata Skin Sciences in Q4 2022 and held it in 4 quarters.
  • Legato Capital Management's Strata Skin Sciences position peaked at $37.6K in Q1 2023.
  • 25 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q4 2023.

Based on Legato Capital Management's 13F filing for Q4 2023, filed 16 Jan 2024.